{"title":"Promising treatment options for antibiotic-resistant Neisseria gonorrhoeae","authors":"","doi":"10.35541/cjd.20210828","DOIUrl":null,"url":null,"abstract":"摘要: 【摘要】 头孢曲松是治疗淋病主要的一线用药,但淋球菌对多种抗生素广泛耐药。为减缓淋球菌的耐药,亟需寻找有效的备选治疗方案。本文从联合疗法、老药新用和新药研发3个方面综述可能有效的抗淋球菌药物。","PeriodicalId":10079,"journal":{"name":"中华皮肤科杂志","volume":"68 5","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华皮肤科杂志","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35541/cjd.20210828","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
耐抗生素淋病奈瑟菌有希望的治疗方案
摘要: 【摘要】 头孢曲松是治疗淋病主要的一线用药,但淋球菌对多种抗生素广泛耐药。为减缓淋球菌的耐药,亟需寻找有效的备选治疗方案。本文从联合疗法、老药新用和新药研发3个方面综述可能有效的抗淋球菌药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。